Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:advantage |
high throughput
non-viral delivery preserves cell viability |
| gptkbp:application |
gptkb:cancer
vaccine development gene editing gene therapy |
| gptkbp:developedBy |
SQZ Biotechnologies
|
| gptkbp:developer |
gptkb:Watertown,_Massachusetts,_USA
|
| gptkbp:enables |
delivery of materials into cells without viral vectors
|
| gptkbp:firstDescribed |
2013
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cell Squeeze technology
|
| gptkbp:mechanismOfAction |
mechanical deformation of cell membrane
|
| gptkbp:patent |
SQZ Biotechnologies
|
| gptkbp:relatedTo |
microfluidics
cell membrane disruption |
| gptkbp:usedFor |
immunotherapy
cell engineering intracellular delivery |
| gptkbp:bfsParent |
gptkb:SQZ_Biotech
|
| gptkbp:bfsLayer |
7
|